Reach Us +1-218-451-2974


Progranulin Deficiency Increases Vulnerability Of Human Neuroblastoma SH-SY5Y Cells To Serum Withdrawal-induced Apoptosis | 21979
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2245

Journal of Alzheimers Disease & Parkinsonism received 2245 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Progranulin deficiency increases vulnerability of human neuroblastoma SH-SY5Y cells to serum withdrawal-induced apoptosis

2nd International Conference on Alzheimers Disease and Dementia

Angeles Martin Requero, Carolina Alquezar and Ana de la Encarnacion

Posters: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460.S1.009

Null mutations in GRN are associated with frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP). However the influence of progranulin (PGRN) deficiency on neurodegenation is largely unknown. In neuroblastoma cells, silencing of GRN gene causes significantly reduced cell survival after serum withdrawal. It was observed that PGRN deficient cells (KD GRN) are more vulnerable to serum deprivation than control cells. The supplementation of recombinant human PGRN restored the survival of KD cells. The following observations suggest that modulation of the CDK6/pRb pathway secondary to changes in the activity of the PI3K/Akt and ERK1/2 signaling pathways, induced by PGRN levels is involved in the altered regulation of serum deprivation-induced apoptosis. (i) The specific CDK6 inhibitors, sodium butyrate or PD332991 sensitized control SH-S5Y5 cells to serum deprivation-induced apoptosis without affecting survival of PGRN deficient cells. (ii) CDK6/pRb seems to be downstream of the PI3K/Aktand ERK1/2pathways since their specific inhibitor, Ly294002 and PD98059 were able to decrease CDK6 activity and induced death of control SH-SY5Y cells. (iii) PGRN deficient cells show reduced stimulation of Akt, ERK1/2, and CDK6-associated kinase activities than in control cells in the absence of serum. These observations highlight the important role of PGRN-mediated stimulation of the PI3K/Akt/ERK1/2 and CDK6/pRb pathways in determining the cell fate survival/death under serum deprivation.
Angeles Martin Requero is Doctor of Biological Sciences, Complutense University of Madrid in 1978. she completed Postdoctoral Fellow in University of Pennsylvania, Philadelphia, USA in 1979-1982. She worked as as a Professor in University of Extremadura (1982-1983). Scientific Holder in 1985. In 1996-1997 she worked as a Visiting Scientist in Medical Scholl, University of California (UCLA), Los Angeles, USA. In 2008 she is a Research Scientist.she currently heads the laboratory devoted to ?study the cellular and molecular basis of Alzheimer?s disease and other dementias, ? in the Department of Cellular and Molecular Medicine, Center for Biological Research (CSIC). She has authored more than 50 publications in international journals and a hundred communications in national and international conferences.